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Abstract
Background: Because of the deceased donor organ shortage, more kidney patients are considering whether to
receive kidneys from family and friends, a process called living donor kidney transplantation (LDKT). Although Blacks
and Hispanics are 3.4 and 1.5 times more likely, respectively, to develop end stage renal disease (ESRD) than Whites,
they are less likely to receive LDKTs. To address this disparity, a new randomized controlled trial (RCT) will assess
whether Black, Hispanic, and White transplant patients’ knowledge, readiness to pursue LDKT, and receipt of LDKTs
can be increased when they participate in the Your Path to Transplant (YPT) computer-tailored intervention.
Methods/Design: Nine hundred Black, Hispanic, and White ESRD patients presenting for transplant evaluation at
University of California, Los Angeles Kidney and Pancreas Transplant Program (UCLA-KPTP) will be randomly assigned
to one of two education conditions, YPT or Usual Care Control Education (UC). As they undergo transplant evaluation,
patients in the YPT condition will receive individually-tailored telephonic coaching sessions, feedback reports, video
and print transplant education resources, and assistance with reducing any known socioeconomic barriers to LDKT.
Patients receiving UC will only receive transplant education provided by UCLA-KPTP. Changes in transplant knowledge,
readiness, pros and cons, and self-efficacy to pursue LDKT will be assessed prior to presenting at the transplant center
(baseline), during transplant evaluation, and 4- and 8-months post-baseline, while completion of transplant evaluation
and receipt of LDKTs will be assessed at 18-months post-baseline. The RCT will determine, compared to UC, whether
Black, Hispanic, and White patients receiving YPT increase in their readiness to pursue LDKT and transplant knowledge,
and become more likely to complete transplant medical evaluation and pursue LDKT. It will also examine how known
patient, family, and healthcare system barriers to LDKT act alone and in combination with YPT to affect patients’
transplant decision-making and behavior. Statistical analyses will be performed under an intent-to-treat approach.
Discussion: At the conclusion of the study, we will have assessed the effectiveness of an innovative and cost-effective
YPT intervention that could be utilized to tailor LDKT discussion and education based on the needs of individual
patients of different races in many healthcare settings.
Trial registration: ClinicalTrials.gov, number NCT02181114.
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Background
Nationwide, there are approximately 615,000 patients
with end-stage renal disease (ESRD), or kidney failure, a
condition that necessitates renal replacement therapy
through either dialysis or kidney transplantation to
sustain life. Transplantation has clear survival and
quality-of-life benefits for patients [1,2] and can reduce
national health-care costs [3]. Living donor kidney
transplant (LDKT) is the optimal form of transplant-
ation since it can occur more quickly than deceased
donor kidney transplant (DDKT) [4,5] and results in
better graft survival [2] and better quality-of-life [6].
Because of the deceased donor organ shortage, most
patients are now considering whether to receive kidneys
from family and friends through LDKT.
Due to higher rates of diabetes and hypertension, the
two primary causes of kidney failure [7], Blacks and
Hispanics are 3.4 and 1.5 times more likely, respectively,
to develop ESRD than their White or non-Hispanic
counterparts [2]. Despite this, research has shown that,
compared to Whites, Blacks and Hispanics are less
likely to complete transplant medical evaluation [8-10], be
placed on the waiting list or have longer wait times
[11,12], or receive DDKTs and LDKTs [2,10,13,14]. Spe-
cifically, at 2 years post-wait-listing, approximately 20% of
both Blacks and Hispanics had received transplants while
30% of Whites had (OPTN data as of 09/19/2014). There-
fore, while increasing the rates of LDKT could increase
the quality-of-life and decrease the mortality of all ESRD
patients, this approach could have its greatest impact on
Black and Hispanic patients’ lives.
Research has indicated that all patients, regardless of
race, face many barriers to getting a LDKT, including a
lack of knowledge about the advantages of LDKT [15],
confusion about how to find living donors [16], concerns
about risking a living donor’s health [15,17], and fears
about the possibility of the transplanted kidney failing
[18,19]. However, there are additional barriers to LDKT
for Black and Hispanic patients. A recent study sug-
gests that Hispanic ESRD patients may have low levels
of knowledge about transplant, particular concerns
about living donors’ wellbeing, and logistical barriers in
the case of undocumented immigrants [20]. With Blacks
and Hispanics less likely to donate kidneys when they
die than Whites, the availability of matching deceased
donor kidneys for this racial group is lower [21,22]. For
racial/ethnic minorities, unsuccessful completion of
transplant medical evaluation and lower receipt of trans-
plants is also exacerbated by lower socioeconomic status,
greater levels of occupational insecurity, and more transi-
ent healthcare coverage compared to Whites [23-25].
Mistrust of healthcare providers is more common
among Blacks and Hispanics than Whites [26,27], which
may affect their trust in physicians’ recommendations
for LDKT and cause suspicion of LDKT itself [26,28,29].
Finally, variation in the availability and quality of a sup-
port network for minorities affects transplantation rates
[9,18,30,31].
In a previous trial, our research team designed a set
of Explore Transplant (ET) print and video education
materials to improve patients’ transplant knowledge
and maximize informed LDKT decision-making [32].
Compared to patients in dialysis centers who received
ET with those in centers who did not, after one month,
patients in ET dialysis centers were more knowledgeable
of transplant, had greater perception of transplant’s
benefits, and were more likely to be reading and talk-
ing to others about LDKT [33]. One to two years later,
more patients in ET dialysis centers were reactivating
or starting transplant medical evaluation [33].
Although the results of this educational intervention
were promising, there is evidence that interventions that
are individually-tailored to ESRD patients’ needs and
preferences may be even more successful at reducing
racial disparities in completion of evaluation and receipt
of LDKTs [34,35]. In this manuscript, we describe the
protocol of a new randomized controlled trial (RCT) to test
the efficacy of a computerized Your Path to Transplant
(YPT) educational program on decreasing racial disparities
in LDKT. The RCT will determine, compared to a usual
care education control group (UC) from the transplant cen-
ter, whether Black, Hispanic, and White patients receiving
YPT increase in their readiness to pursue LDKT and trans-
plant knowledge, and whether they become more likely to
complete transplant medical evaluation and pursue LDKT.
It will also examine whether YPT’s effectiveness in
changing LDKT decision-making and behavior is differ-
ent between Blacks, Hispanics, and Whites. Finally, it
will examine how known patient, family, and healthcare
system barriers to LDKT act alone and in combination
with YPT to affect Black and Hispanic patients’ trans-
plant decision-making and behavior.
Methods and study design
Theoretical foundation of YPT
Guided by the Transtheoretical Model of Behavioral
Change (TTM) [36], one proven approach for health
promotion is to individually-tailor education by the level
of patients’ readiness to take certain health behaviors
and other decision-making variables, like the patients’
self-efficacy [37-42]. The TTM is particularly well-suited
for the development of computer-tailored interventions
(CTIs) that can be easily disseminated to entire popula-
tions. By utilizing relevant theory, normative databases
and empirically-based decision rules, CTIs provide tailor-
ing of the most appropriate information to each partici-
pant to guide their change process. This approach allows
for thousands of unique combinations of individual
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feedback messages to be provided based on TTM con-
structs [38].
CTI feedback provided to patients via coaches and
printed reports addresses how a specific patient’s know-
ledge and readiness to take a specific behavior compares
to a normative group of patients (normative feedback)
or changes over time compared to their own previous
data (ipsative feedback). Individually-tailored interventions
provide recommendations to educators to guide health
conversations optimally that emphasize what is most
helpful to the patient, minimize resistance, and emphasize
key demographic or socioeconomic factors, if needed.
Research has shown that patients who receive education
tailored to their level of readiness have double the
chance of taking action toward behavior change in the
following 6 months [43].
Design and advantages of YPT
YPT was developed by Dr. Amy Waterman, creator of
the Explore Transplant (ET) Patient Education Program
[32,33], and experts in TTM behavior change, Drs. Mark
Robbins and Andrea Paiva. For several reasons, we an-
ticipate that the YPT educational program may be more
effective than usual care education provided by trans-
plant centers (Table 1). A unique and innovative element
of YPT is the TTM-based CTI using validated transplant
decision-making measures [44,45] that can be delivered
in person, via the telephone, and on the computer. First,
the computer-generated content within this program is
individually-tailored to patients’ levels of readiness to
pursue DDKT and LDKT. In addition to their level of
readiness, behavioral guidance is based on TTM con-
structs (including decisional balance and self-efficacy),
addresses their unique gaps in knowledge, and discusses
information relevant to any personal challenges patients
could be facing to derail them from transplantation.
Since the YPT assessment can be given at different time
points throughout evaluation, patients’ changes in know-
ledge, readiness, and other TTM constructs over time
can be assessed and tailored feedback communicated
by coaches. Second, the program is delivered over four
time points in small increments, recommending patients
take small, more manageable steps toward pursuing
LDKT. This empowers patients to feel they are making
meaningful progress toward LDKT and honors that many
ESRD patients experience mental fatigue when too much
educational information is provided at one sitting. Third,
since the YPT program acknowledges that DDKT and
LDKT are two separate treatment options and choices, it
addresses patients’ individual fears and readiness for
DDKT and LDKT separately. Finally, the YPT program
provides community-based resources and coaching to
help overcome socioeconomic and other practical barriers
that may derail transplantation.
To ensure that the individually-tailored feedback is
medically accurate and culturally competent, we recruited
an Advisory Board of key content and medical experts
including transplant coordinators, nephrologists, kidney
recipients, and researchers with expertise in developing
culturally sensitive interventions that address the needs
of low health literacy groups. The Advisory Board has
advised in the development of, and approved of, all
components of our educational intervention.
YPT educational components
YPT tailored feedback
The YPT individually-tailored feedback report includes
sections about the patient’s knowledge about transplant
(DDKT and LDKT), readiness to pursue transplant, per-
ceived pros/cons to transplant, confidence in pursuing
transplant, and potential socioeconomic barriers to trans-
plant (Figure 1 and Table 2). As prompted by bulleted
coaching points generated by the YPT CTI, the coach will
discuss gaps in a patient’s specific transplant knowledge
based on what questions they missed and will recommend
small next steps to take (e.g., “Ask another person to
tell others about your need for a living donor trans-
plant”) based on their level of readiness to pursue
DDKT/LDKT.
The coach will also discuss the benefits of DDKT and
LDKT and provide suggestions for any concerns mentioned
in the assessment (e.g., “You are concerned that if the
transplant fails, it would have been a lot of work and pain
for nothing. The first thing to know is that transplants, in
general, are very successful […]”) or issues that are reducing
patients’ confidence in being able to successfully pursue
LDKT (e.g. “It seems that you are not feeling very confident
that you could take actions to pursue living donor trans-
plant. Finding a living donor isn’t always easy. It can take
time and can sometimes be disappointing, if family mem-
bers or friends don’t volunteer or match. It’s important to
be patient and creative when problems emerge, and to stay
hopeful. […]”) Finally, coaches will provide resources and
strategies that may assist with overcoming socioeconomic
barriers to transplant.
YPT coaches
The YPT Coaches, who have expertise in social work,
psychology, public health, nursing and health communi-
cation, deliver the CTI-generated recommendations to
patients in person and by telephone. Before conducting
the program, each coach will have: 1) been assessed to
be proficient in the use of the YPT computer program;
2) completed 6 hours of cultural-sensitivity training; 3)
reviewed the study’s field training manual and key trans-
plant literature; 4) participated in training about the TTM;
5) completed role play and practice coaching exercises
with an Expert TTM Trainer and patients; and 6) learned
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about community resources available to help overcome
socioeconomic barriers to transplant. A coach is trained
to approach the patient in an empathetic, non-judgmental
way.
YPT supplementary education materials
Finally, many brochures, fact sheets, and videos based
on Dr. Waterman’s previous qualitative and quantitative
research will be used in the YPT program [10,33,44,45]
(Table 2). Transplant recipients and living donors in the
videos represent patients of different races, ethnicities,
and socioeconomic groups. All educational materials are
written for patients with low health literacy. Along with
the individual feedback reports, specific combinations of
these materials will be mailed in folders to review at
home, based on the patient’s level of LDKT readiness at
that specific time-point.
Videos will also be provided to patients in the YPT
intervention condition. First, based on their level of LDKT
readiness, patients will watch one of two 8-minute videos
on evaluation day, either a video discussing general advan-
tages to pursuing LDKT or a more advanced video provid-
ing practical suggestions for how to find living donors.
Second, the patient will be given a one-hour Explore
Transplant video to review at home with people who help
them make important health decisions. The videos include
the stories of 20 transplant recipients and living donors
and discuss the questions and fears they had before
getting a transplant and why they became motivated to
pursue transplant. Health professionals on the video and
educational fact sheets provide answers to common ques-
tions, including specifics about the evaluation, surgery and
recovery processes involved with being a transplant recipi-
ent and a living donor. The benefits and risks of being a
kidney recipient and a living donor are also outlined. This
video is closed-captioned for the hearing impaired.
This program also invites family members and friends
to learn with the patient. The patient will receive a Guide
for Family Members and Friends that provides suggestions
about how others could help the patient learn, decide
what is best for them, and, potentially, be living donors
themselves.
Community resource guide to address socioeconomic
barriers to transplant
A Community Resource Guide will also be given to patients
to provide them with referrals to services that may help
them overcome socioeconomic barriers to transplant.
Referral resources include access to dental services, re-
duced or free childcare or transportation services, and in-
expensive housing near the transplant center. The coaches
will refer the patients to specific resources within the
Table 1 Advantages of Your Path to Transplant computer-tailored education
Innovation Implementation Resource
Tailors education to individual
patient needs
□ Tailored based on individual patients’ transplant
knowledge and decision-making
TTM-based computer–tailored intervention
that was designed to track a patient’s
attitudinal shifts over time
□ Provides information and recommends steps to
pursue transplant in small doses at multiple time
points
□ Tracks patients’ knowledge and attitudinal shifts
over time, allowing coaches to acknowledge growth
and change
Provides education in multiple
media/formats
□ Provides education in multiple formats to account
for multiple learning styles, including video stories,
provider-led coaching sessions, and individually-
tailored reports
Cultural competency-trained coaches providing
individualized coaching to the patient and
disseminating educational pamphlets, factsheets
and a DVD that highlights the experiences of
kidney donors and recipients
□ Includes an in-person educational session with
each patient to develop greater relationship
between the patients and the coaches
□ Provides a culturally competent and
socioeconomically sensitive coach to help guide
patients through the education and transplant
process for deceased and living donor transplant
separately
Engages external resources to
help patients pursue transplant
□ Includes educational resources to engage
patients’ support networks and potential living
donors to learn about transplant along with the
patient
A guide for family and friends is available for
those family members and close friends of
patients who want to learn about kidney
transplant
□ Provides resources to help patients overcome
socioeconomic barriers limiting their access to
transplant
Patients are given a 43 page community
resource guide that contains information
ranging from dental services to low cost
transportation in the LA County area
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guide if the patient expresses concerns about not being
able to successfully pursue transplant due to these types of
barriers.
Usual Care (UC) educational components
The transplant education of kidney patients at UCLA-
KPTP randomized to the UC education condition will
take place predominately during evaluation at the trans-
plant center and afterwards, by telephone, as needed
(Table 3). Three to five weeks after scheduling a transplant
evaluation appointment, the patient will come to UCLA-
KPTP to attend a transplant educational seminar and
complete a series of medical, psychological and financial
tests to screen for health problems or other concerns that
could affect the success of the transplant. Patients who
pass all of these tests are called transplant candidates.
During evaluation, the two-hour transplant education
seminar will be delivered by a social worker or nurse to
a group of transplant patients and any family members
or friends who are present. The transplant coordinator
will deliver a PowerPoint presentation that outlines the
evaluation, surgery, and recovery processes, how to fi-
nancially prepare for transplant and communicate with
the transplant team, possible resources for housing and
transportation, and caregiver obligations post-transplant.
In regards to LDKT, the coordinator discusses how to
obtain a LDKT, who is eligible to be a living donor, the
available paired donation programs, and what the donor
can expect during evaluation and surgery. The patients
receive a copy of the PowerPoint slides and a “Patient
Education Manual”, that includes additional printed
education regarding the transplant and living donation
processes, recipient selection criteria, nutrition, and exer-
cise. They also receive education about LDKT including
two pamphlets discussing incompatible blood type and
kidney transplantation and the UCLA kidney exchange
program.
During their one-on-one evaluations with the transplant
coordinator, social worker, nephrologist and/or surgeon,
patients have the opportunity to ask additional questions.
Additional educational opportunities are also available by
phone after evaluation when speaking with their transplant
coordinator while completing their final medical tests and
tracking their progress on the waiting list.
RCT overview
In this study, we will conduct an educational intervention as
Black, Hispanic, and White ESRD patients present for and
undergo transplant evaluation, and take actions to pursue
DDKT and LDKT. This longitudinal, parallel RCT has two
treatment conditions with equal allocation, the YPT Inter-
vention and the UC control education conditions (Figure 2).
Patients in both groups will be surveyed prior to presenting
at the transplant center (baseline), and at 4- and 8-months
post-baseline. Patients in the intervention group will also be
surveyed an additional time during their in-person trans-
plant evaluation meeting. Completion of transplant evalu-
ation and receipt of LDKT will be assessed for both groups
using medical records 18-months post-baseline.
Patients in the YPT and UC education conditions will
receive identical UCLA-KPTP education during transplant
evaluation for an estimated 3 hours and will continue to
learn on their own afterwards. Patients in the YPT inter-
vention group also will receive additional sources of
Figure 1 Example feedback reports.
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transplant education including individualized feedback re-
ports, print and video education resources, and coaching
at four time points: a few weeks before and during trans-
plant evaluation, and 4 and 8 months after baseline.
Patients in the intervention (YPT) condition will receive
an estimated 1 hour and 15 minutes of additional formal
transplant education compared to patients in the UC con-
dition over an 8 month period.
Table 2 Your Path to Transplant education materials and delivery timepoints
Timepoint Education delivered Time required
At baseline ▪ Computer-tailored feedback report for the individual patient based on
their DDKT and LDKT readiness, decisional balance, self-efficacy, and
transplant knowledge.
25 minutes
▪ Coaching recommendations for the individual patient.
▪ What You Need to Know About Kidney Transplant Booklet introduceda:
19 facts about the benefits and risks of transplant and the transplant
evaluation and surgery process.
▪ What You Need to Know About Living Donation Booklet introduceda:
15 facts about the benefits and risks of living donation and the living
donation evaluation and surgery process.
▪ A Community Resources Guide introduceda: A guide providing referrals
to community services like reduced or free childcare or transportation
services, and inexpensive housing near the transplant center for patients
who are facing socioeconomic barriers to transplant.
During evaluation ▪ Computer-tailored feedback report for the individual patient based on
their DDKT and LDKT readiness, decisional balance, self-efficacy, and
transplant knowledge.
20 minutes
▪ Coaching recommendations for the individual patient.
▪ LDKT Education, based on LDKT Readiness Stage, either:
○ Review and discuss Why People Donate Their Kidneys Brochure:
Provides a list of reasons why living donors decided to donate a
kidney to someone in need. Given to patients in LDKT readiness
stages of Precontemplation and Contemplation.
○ Review and discuss How to Find a Living Donor Brochure: Suggests
small steps potential kidney recipients can take to find potential living
donors. Given to patients in LDKT readiness stages of Preparation and
Action.
▪ A Guide for Family & Friends Brochure: This brochure offers small steps
family members and friends can take to support the patient in completing
evaluation successfully and, if interested, pursuing LDKT.
▪ Explore Transplant DVD: This 4-part video discusses why patients decided
to pursue transplant, why living donors decide to donate, the recipient and
living donor evaluation and surgery processes, the risks and benefits to
transplant, and how patients lives have changed.
4 months post-baseline ▪ Computer-tailored feedback report for the individual patient based on
their DDKT and LDKT readiness, decisional balance, self-efficacy, and
transplant knowledge.
15 minutes
▪ Coaching recommendations for the individual patient.
▪ Additional LDKT education, as their LDKT stage of readiness changes
over time.
▪ Additional copies of the Community Resources Guide to support them
as their socioeconomic barriers change over time.
8 months post-baseline ▪ Computer-tailored feedback report for the individual patient based on
their DDKT and LDKT readiness, decisional balance, self-efficacy, and
transplant knowledge.
15 minutes
▪ Coaching recommendations for the individual patient.
▪ Additional LDKT education, as their LDKT stage of readiness changes
over time.
▪ Additional copies of the Community Resources Guide to support them
as their socioeconomic barriers change over time.
aThese materials are introduced during the education session and then mailed to the patient.
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Patient recruitment, eligibility, randomization, and retention
The records of patients who have recently been scheduled
for their evaluation day appointments will be obtained
from UCLA-KPTP’s clinical database, randomized to a
treatment group by a data manager, and uploaded into a
patient recruitment and tracking database supported by
the Research Electronic Data Capture (REDCap) software
[46]. Research staff will contact patients by telephone
to be invited to participate in the study. The REDCap
recruitment database will include eligible patients’
names, contact information, demographic data, data
on their retention in the study and progress through
the survey time points, and their final clinical out-
comes at the end of the trial. It will be continually up-
dated by the study research coordinators and a data
manager.
Table 3 Usual care education materials and delivery timepoints
Timepoint Education delivered Time required
During evaluation • Power point that outlines the transplant process from evaluation to post-transplant.
The second portion of the presentation focuses on financial preparation, resources
for housing and transportation, and caregiver obligations post-transplant.
2 hours
• Patient Education Handbook that contains information regarding the transplant
process, the Kidney and Pancreas Transplant Program selection criteria process,
transplantation and hepatitis c/HIV, the role of social services, additional information
about nutrition and staying fit as well as information for potential donors and what
they can expect throughout the process.
• Discussion with transplant coordinator, nephrologist, surgeon, financial coordinator,
and social worker during evaluation.
After evaluation • Additional discussions with transplant coordinator, nephrologist, surgeon, financial
coordinator, and social worker after evaluation.
1 hour
Figure 2 Your Path to Transplant study design flowchart.
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Inclusion criteria for the RCT include: 1) presentation
for transplant evaluation at UCLA by calling to make an
appointment; and 2) self-identification as either White,
Black or Hispanic race/ethnicity. Exclusion criteria include:
1) being under age 18; 2) not being able to speak English;
3) being previously deemed ineligible for transplant at
UCLA; 4) being on the wait-list for transplant at a center
other than UCLA; 5) pursuing multi-organ transplant; or
6) having no consistent access to a working telephone.
After being informed of the risks and benefits of the trial,
patients will be asked to give verbal informed consent
to participate and have their electronic medical re-
cords reviewed. This protocol has been approved by
the University of California, Los Angeles’s Internal Review
Board (#14-000382) and registered at ClinicalTrials.gov
(#NCT02181114).
We will recruit 900 patients at baseline, 450 per
treatment group. We estimate a conservative attrition
rate of approximately 33%, resulting in a final sample
of approximately 600 subjects, 300 in each group. To
maximize participation and minimize attrition, we will
provide a $10 incentive upon completion of each of the
3 or 4 time points (depending on treatment group), pay
for the costs of transplant center parking and provide
snacks at evaluation day, and collect alternative contact
information at baseline in case of study dropout. We also
have the ability to monitor patients’ progress through
transplant evaluation daily using electronic medical re-
cords, which will greatly reduce the number of patients
who are lost to follow-up.
Survey timepoints
To begin the trial, we will conduct a 40-minute assessment
of patients in the YPT and UC conditions to measure
their demographic and clinical characteristics, any so-
cioeconomic barriers to transplant, as well as their base-
line DDKT and LDKT knowledge, decision-making,
readiness, and self-efficacy. Upon beginning evaluation
approximately 3–5 weeks later, patients in the YPT con-
dition will repeat components of the survey during a 10-
minute assessment. Four and 8 months later, patients in
both conditions will complete two more 15-minute
surveys to assess how their knowledge, decision-
making, and behavior are changing over time. During
the final 8-month interview, we also will ask patients
questions regarding the cultural competency of their
medical providers and other process measures including
whether they had made an informed decision as to
whether or not pursue DDKT or LDKT, and the overall
helpfulness of the education they received.
For patients in the UC education condition, no add-
itional education or coaching will occur after these surveys
are administered. Patients in the UC education condition
will receive a $10 gift card and a letter of thanks in the
mail after each time point. Patients in the YPT condition
will receive additional education and tailored coaching, as
discussed next.
YPT baseline education and coaching
Typically within 14 days post-baseline survey, patients
randomized to YPT will have a separate 25-minute base-
line coaching telephone call. During this call, as prompted
by bulleted coaching recommendations generated by the
YPT computerized program, the coach will discuss the
most relevant content to support each patient in complet-
ing transplant evaluation successfully and pursuing LDKT.
Immediately after the call, the coach will mail each patient
a folder containing the informed consent documents, an
individually-tailored feedback report generated from their
answers to the baseline survey, print DDKT and LDKT
educational resources, including a Community Resource
Guide, and a $10 gift card.
YPT evaluation day education and coaching
On evaluation day, 3 to 5 weeks after baseline, patients
in the YPT intervention condition will be taken to a
private area in the hospital where they will be reassessed
to see how their transplant decision-making is changing.
Then, the coach will provide 10-minutes of feedback
based on any changes in readiness, confidence, and
perceived benefits or concerns that have occurred since
the initial assessment. Since the focus of this meeting is
LDKT, patients also will watch a 10-minute LDKT video
appropriate for their level of readiness and a discussion
will be held about small steps they could take that honor
their stage of readiness to further explore or pursue
LDKT (20 minutes total time). At the end of the session,
the coach will give the patient a second folder including
an individually-tailored feedback report, print educa-
tional materials about LDKT, including an Explore
Transplant video, educational resources to share with
their family members and friends, and a $10 gift card.
This meeting will take 30 minutes (20 minutes of coaching
and 10 minutes for survey assessment).
YPT 4- and 8-month education and coaching
During two additional telephone assessments at 4- and
8-months following baseline, patients will be resurveyed
(15–20 minutes) to see how their decision-making and
behavior is changing and, in the YPT education condition
only, surveyed at 8 months about YPT’s helpfulness.
Tailored coaching (15 minutes) will be given by tele-
phone and individual feedback reports and $10 gift
cards mailed following the phone call.
YPT coaching fidelity
Throughout the intervention, the coaches will participate in
weekly calls with a clinical psychologist, Dr. Mark Robbins,
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to discuss questions and continue to improve the tailored
coaching process. Coaches administering the YPT interven-
tion will be assessed for fidelity using a standard rubric
[47]. All patient interviews will be audio recorded with the
patient’s consent. For each coach, the first 10 calls will be
reviewed to ensure competency, then, afterwards, a ran-
domly selected 10% of their calls will be reviewed by two
raters and checked to see if the content and dose of the
intervention has been delivered consistently, per protocol.
Coaches administering the intervention and coaching to
the intervention group will be rated on: 1) their standard-
ized interviewing technique; 2) the consistency of coach-
ing to TTM principles (e.g., effective tailoring to stage of
readiness); 3) effective delivery of additional trial compo-
nents (e.g., addresses socioeconomic status barriers to
transplant, cultural competency); and 4) effective commu-
nication skills and rapport. Coaches scoring below a mini-
mum threshold will be required to undergo further
training before continuing with the trial.
Outcome measures
LDKT and DDKT readiness
Using validated measures [44,45], patients will be asked
how ready they are to get a DDKT by reporting whether
they are “not considering getting a DDKT in the next six
months” (Precontemplation), “considering getting a DDKT
in the next six months” (Contemplation), “preparing to
get a DDKT in the next 30 days” (Preparation), “under-
going evaluation to get a DDKT” (Action) or “listed and
waiting to get a DDKT” (Maintenance) [44]. Patients will
also be asked how ready they are to pursue LDKT and to
rate whether they are “not considering taking actions in
the next six months to pursue LDKT” (Precontemplation),
“considering taking actions in the next six months to pur-
sue LDKT” (Contemplation), “preparing to take actions in
the next 30 days to pursue LDKT” (Preparation), or “tak-
ing actions to pursue LDKT” (Action) [45].
Small steps toward LDKT and DDKT
To assess their steps toward transplant, patients will be
asked to respond whether they have “Already done”, “Are
planning to do”, or “Don’t plan to do” a list of actions re-
lated to LDKT [45] and DDKT [44]. Examples of steps to-
ward LDKT include “Read information/watch videos
about getting a living donor transplant” and “Ask potential
donors to be tested”, while examples of steps toward
DDKT include “Share educational materials about de-
ceased donation with people in your life” and “Follow-
up with the transplant coordinator until transplant
evaluation is complete”.
Decisional balance and self-efficacy
Decisional Balance measures will assess how patients
weigh the relative importance of possible LDKT and
DDKT positive and negative outcomes (e.g., “My living
donor will feel good seeing my health improve”). Patients
will be asked to rate the importance of each statement
on a 5-point scale ranging from, (1) “Not important” to
(5) “Extremely important” [44,45]. The Self-Efficacy scale
measures the confidence an individual has in his/her ability
to pursue transplant in a wide variety of challenging situa-
tions (e.g., “If your friends and family were unsupportive
of you getting a transplant”) on a scale from (1) “Not at all
confident” to (5) “Completely confident” [44,45].
Transplant knowledge
Patients will be asked 11 true/false and 8 multiple choice
questions to determine their level of knowledge regard-
ing basic facts, advantages, risks and outcomes of DDKT
and LDKT (e.g., “Patients older than 80 years can receive
transplants”; “Compared to transplants from donors who
have died, how long do transplants from living donors
last?”) [10]. A measure of transplant knowledge is then
created by summing the number of correct answers to
the questions.
Final transplant outcome
Finally, patients’ electronic medical records at UCLA
and data from the Scientific Registry for Transplant
Recipients (SRTR) will be reviewed 18 months post-
baseline to create a final study outcome for each patient.
At the study’s conclusion, the patient will be coded as to:
1) be waitlisted for a DDKT; 2) have received a DDKT;
3) have received a LDKT; 4) have been determined to be
medically ineligible for transplant; 5) have died; or 6) have
dropped out of evaluation.
Predictors and covariates
Demographic, clinical and cultural factors
Many other patient characteristics will be assessed in-
cluding age, sex, race/ethnicity, dialysis status (on or
off dialysis; if on, hemodialysis or peritoneal), patient
comorbidities (e.g., the presence of diabetes, hyperten-
sion, polycystic kidney disease) and validated measures
of health-related quality of life, including the Medical
Outcomes Study (MOS) SF-12v2 [48] and a patient-
reported Karnofsky rating of health status [49]. To
examine how other known causes for health disparities
in transplant affect key outcomes we will also assess
medical mistrust using the Medical Mistrust Index, a
validated scale that assesses patients’ agreement with
7-items about their trust of health care organizations
(E.g., “Patients have sometimes been deceived or misled
by health care organizations”) [29,50].
Socioeconomic transplant derailers
Multiple characteristics also are thought to be associated
with having greater levels of socioeconomic stressors
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that may impact successful completion of transplant
evaluation. These include patients’ education level, the
type of health insurance they have (private, government,
multiple sources, no insurance), and their employment
status (full time, part time, disability, other financial
assistance programs, no employment). Additional mea-
sures such as income vulnerability (e.g., “If your family
lost your current income, how long could you continue
to live in your current situation?”) [51], family obligations,
access to transportation [52], and feelings of safety in their
neighborhood will also be assessed to determine the level
of vulnerability each patient faces. Lastly, patients will be
asked a series of two open-ended questions to determine:
1) how personal life factors might make it difficult to get a
transplant (“What are you dealing with that might get in
the way of you pursuing transplant?”) and 2) what plans
the patient already has in place to overcome the identified
barrier (“Do you have any ideas about how you could
make sure that this doesn’t stop you from pursuing
transplant?”).
Social support and availability of living donors
Social support will be assessed by examining discordance
on responses to two items measured on a 4-point Likert
scale ranging from “None” to “A great deal”: “In the past
6 months, how much help or support have you received,
related to your kidney disease?”; “In the past 6 months,
how much help or support have you needed, related to
your kidney disease?” [52]. Availability of donors will be
assessed by measuring the number of close and extended
family members and friends a patient has, presence of kid-
ney disease or other comorbidities (e.g., diabetes and hyper-
tension) in these groups, and the number of donor offers.
Transplant education and health literacy
Patients’ previous transplant education will be evaluated
with four “Yes/No” questions that explore whether they
have: 1) read brochures, 2) watched videos, 3) browsed
the internet, and 4) talked to doctors or medical staff
about LDKT or DDKT. Patients responding “Yes” to any
of the items will then be asked how much time they have
spent learning about transplant through that distinct
method. Subjective health literacy and numeracy [53] will
be assessed with two items scored on Likert-type scales:
“How often do you have someone (like a family member,
friend, hospital/clinic worker or caregiver) help you read
hospital materials?”, “How confident are you filling out
forms by yourself?”
Evaluation and process measures
At the 8 month assessment, or if patients receive a
transplant or are deemed permanently ineligible for
transplant before then, patients will be asked to assess
the cultural competence of their healthcare providers
during the evaluation process (e.g., “How often were you
treated unfairly at the transplant center because of your
race or ethnicity?”) on a 4-point scale ranging from “Never”
to “Always”. Cultural competence will be further explored
with 4 items that assess how much patients agreed that
they felt trust and concern from their providers (e.g., “Did
you feel you could trust them with your medical care?”;
“Did you feel they really cared about you as a person?”). All
cultural competence measures were adapted from the Con-
sumer Assessment of Healthcare and Provider Systems
(CAHPS) Clinician & Group Survey [54].
Patients will also be asked a series of questions about
their informed decision making. The decisional conflict
scale [55] was adapted to reflect three kidney disease
treatment options including remaining on dialysis, get-
ting a DDKT, and taking actions to pursue LDKT. After
identifying which treatment option(s) they have chosen,
patients will be asked to evaluate their decision (e.g., “I
know the risks and side effects of each option”; “I am
choosing without pressure from others”; “I am satisfied
with my decision”) using a 5-point, Likert-type scale ran-
ging from “Strongly Agree” to “Strongly Disagree”. To
assess whether a patient has made an informed decision,
patients will respond using a 4-point Likert-type scale
ranging from “Completely Disagree” to “Completely
Agree” to the following questions: “I have all the facts I
need to make an informed decision about whether or not
to pursue deceased donation” and “I have all the facts I
need to make an informed decision about whether or not
to pursue LDKT”.
Data management and statistical considerations
To ensure confidentiality and security of patients, all
data, including de-identified audio-recordings of patient
interviews, will be stored in university-maintained,
encrypted, password protected servers. Also, in accord-
ance with NIH policy, we have established a data safety
and monitoring board to monitor our trial’s progress. All
study data will be captured in two electronic databases.
First, registration data, patient demographics, patient
tracking fields, and transplant status/medical records
will be captured in a REDCap patient registration system
[46]. Study personnel can check on patients’ records by
examining their data entry form or through reports gener-
ated in REDCap. The records of patients who refuse to
participate or are never successfully recruited to the study
will be retained in the REDCap registration database and
de-identified at the end of the study so that patterns in
recruitment can be analyzed and reported.
Second, assessments of transplant decision-making,
factors that could derail patients in their pursuit of
transplant, health literacy, medical mistrust, and social
support at baseline, 4 and 8 months post-baseline and
relevant coaching recommendations will be captured in
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the YPT computerized survey and coaching program.
The YPT system has been programmed using Pro-Change
Behavior Systems, Inc.’s proprietary behavior change
software that utilizes spreadsheets, within which statistical
decision rules for generating patient feedback, assessment
questions and response options, and multimedia specifica-
tions are programmed and configured. An offline Java
process converts the information on these project con-
figuration spreadsheets into Java objects, and stores the
Java objects in a single serialized file. Then TTMX, a
Java application, accesses the rules defined in the serial-
ized file to give TTM-based, individualized feedback. As
a participant proceeds through the program, TTMX
compiles the text and graphic components of each
screen based on the participant’s responses and on what
have been programmed in the spreadsheets. The statistical
decision rules are derived from multivariate analyses. An
integrated back-end database allows for dynamic stored
responses which enables dynamic tailoring. The integrated
database allows for a fully-integrated user experience
regardless of their chosen method of engagement (i.e.,
coaches, online, and others).
Power and sample size
The sample size and power calculation for this trial was
treated as a test of the proportional differences between
YPT and UC patients in the Action stage of LDKT readi-
ness at 8-months post-baseline. Based on previous work,
we conservatively estimated that, at 8 months post-
baseline, 10% of UC patients and 20% of patients in YPT
group would reach the Action stage [10,33]. Assuming a
one-tailed alpha of 0.05, a sample size of 300 patients
per group is required at 8 months post-baseline to
achieve power of 0.80 (total n = 600). Assuming an 8-
month post-baseline retention rate of 66%, a total sam-
ple size of 450 per education condition will need to be
recruited/consented at baseline (n = 900). This sample
size will provide sufficient sensitivity to detect a differ-
ence in increase in LDKT readiness (i.e., moving to Ac-
tion) of about 10% between treatment (YPT) and
control (UC) groups using logistic regression.
Statistical analyses
All statistical tests will employ an intent-to-treat (ITT)
approach wherein subjects will maintain their assignment
to the treatment condition to which they were originally
randomized regardless of whether they actually end-up re-
ceiving the planned interventions or not [56]. Multiple im-
putation of missing data will be used for the analyses [57].
The alpha level for all tests will be set at 0.05, and random
effects models will be used to account for longitudinal
measurement and linear regression employed for normally
distributed outcomes, logistic regression for binomially
distributed outcomes, and Poisson regression for count
outcomes. The social, demographic, and other characteris-
tics of patients who refuse to join the study or are never
successfully contacted will be compared to those who do
not to determine if the patient selection procedure has
resulted in a biased sample. A similar analysis will be
conducted to compare the patients who drop-out of the
study to those who do not to determine if patient attrition
has biased the sample.
To test whether, compared to the UC education con-
dition, Black, Hispanic, and White patients receiving
YPT increase in their LDKT readiness, we will first
examine the proportion of individuals moving into the
Action stage for readiness to accept a LDKT 8 months
post-baseline between the YPT and UC conditions. For
a more fine grained assessment of change in LDKT and
DDKT readiness throughout the study, change by three
occasions (baseline, 4 months post-baseline, and 8 months
post-baseline) will be examined. To assess differences in
transplant knowledge, DDKT/LDKT self-efficacy, and
DDKT/LDKT decisional balance, comparisons between
the YPT and UC conditions by these three occasions will
be made to determine if the intervention increases
transplant knowledge, DDKT/LDKT self-efficacy, and
DDKT/LDKT decisional balance scales. Finally, differ-
ences in the number of small steps toward LDKT and
DDKT will be examined at these three time points.
To determine whether, compared to the UC group,
Black, Hispanic and White patients receiving YPT are
more likely to complete transplant medical evaluation
and pursue LDKT 18-months post-baseline, regression
models will be fit with: 1) only the treatment condition
as a predictor; 2) race added-in as a covariate; 3) an
interaction term between treatment and race. To examine
whether the YPT’s effectiveness in changing LDKT
decision-making and behavior is different between Blacks,
Hispanics and Whites, comparisons will be made of pro-
portional forward movement in readiness at 8 months
post-baseline between Black, Hispanic and White patients
in the YPT condition. Also, Black, Hispanic and White pa-
tients will be compared on three occasions (baseline, 4
months post-baseline, and 8 months post-baseline) to de-
termine if access to YPT increases transplant knowledge
differently for Black, Hispanic and White patients through
this follow-up period and if the intervention has different
effectiveness on the increase in proportion of living donors
being evaluated for LDKT and increases in the proportion
of LDKTs among Black, Hispanic and White patients
18-months post-baseline.
Finally, to examine how known patient, family, and
healthcare system barriers to LDKT act alone and in
combination with YPT to affect Black and Hispanic
patients’ decision-making and behavior around LDKT,
the direct effects of key modifiable and non-modifiable
variables known to affect disparities in receipt of LDKT
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(e.g., medical mistrust, quality of health insurance, phys-
ician recommendation to pursue LDKT) on readiness to
pursue LDKT, transplant knowledge, completion of trans-
plant evaluation, and receipt of LDKT will be adjusted for
in regression models of YPT’s effect on these outcomes
for Blacks and Hispanics separately. Then, interactions be-
tween YPT and these factors will be added to the models.
Specifically, we will model each dependent variable first
using the main effects of the barrier variables and of the
YPT intervention, and then add two-way interactions
between the intervention and the barrier variables.
Similar models will be constructed for White patients.
Based on these models, we will determine: (1) the es-
timated magnitude of racial differences between Black,
Hispanic and White patients with and without access
to the YPT for each outcome, and (2) which patient
and care-related variables represent important con-
founding and modifying effects for explaining racial/ethnic
differences in each outcome. These analyses will help eluci-
date whether the YPT achieves results by attenuating the
impact of specific ‘causes’ of racial/ethnic disparities in
LDKT.
Qualitative analyses will be performed to understand re-
sponses to key open-ended questions asked in the survey,
particularly those around socioeconomic barriers to pa-
tients’ pursuit of transplant, potential solutions to barriers
patients face in their transplant pursuit, and actions pa-
tients are willing to take toward LDKTand DDKT. Patients’
responses will be coded and analyzed to determine themes.
Discussion
In every transplant center in the country, there are racial
disparities in the receipt of LDKTs [58]. Active educational
interventions to increase Black and Hispanic patients’ pur-
suit of LDKT have demonstrated some success [27,59-62].
For example, in one dialysis center study, compared to their
baseline attitudes, Blacks, younger patients, and patients
who spent less time on dialysis were significantly more will-
ing to pursue LDKT after receiving a print and video-based
intervention compared to patients who did not receive this
program [60]. In transplant center studies, compared with
traditional clinic-based education, significantly more pa-
tients in a home-based educational intervention condition,
particularly Blacks, had living donor inquiries, evaluations,
and LDKTs [61,63,64]. Further, two important trials are
underway that will develop and assess the effectiveness of:
1) culturally sensitive education to improve kidney disease
patients’ early consideration (pre-ESRD diagnosis) of LDKT
with and without the assistance of a social worker [65];
2) group- and individual-based LDKT education at patients’
homes and in transplant centers [66]. Less interventions
aimed at Hispanic patients have been conducted, though a
culturally sensitive transplant evaluation process for
Hispanic patients providing linguistic support in Spanish
and transplant education that focuses specifically on con-
cerns among Hispanic patients was successful in increas-
ing Hispanic patients’ knowledge of and positive attitudes
about living donor transplant [27].
While these trials have, or promise to, contribute
important evidence about how best to reduce racial
disparities in LDKT, a common limitation among them
is that they are not tailored to patients’ individual
readiness, self-efficacy, or confidence to pursue LDKT.
The proposed YPT RCT is novel because it assesses the
effectiveness of an individually-tailored health education
intervention and personalized coaching system to reduce
racial disparities in LDKT. The findings of this trial will
foster greater understanding of how YPT specifically af-
fects White, Black and Hispanic patients’ LDKT decision-
making, knowledge, and behavior.
Another novel feature of the YPT trial is its ability to
examine the impact of socioeconomic factors that may
derail White, Black and Hispanic patients’ pursuit of LDKT.
Past studies have demonstrated that patients of lower socio-
economic status are less likely to successfully complete
transplant evaluation [14,67]. However, these studies have
compared the relative effects of few socioeconomic factors
simultaneously [10,11,68], focused exclusively on factors
that are difficult to modify (e.g., type of health insurance
or household income) [11,68], or employed measurement
at the neighborhood or census block level [14,68,69]. In
YPT, after assessing key, specific barriers and providing
support services to address them, we will be able to pin-
point the factors most likely to interfere with evaluation
completion and successful LDKT.
In conclusion, through this trial, we will have developed a
computerized Your Path to Transplant tailored computer
intervention that could be utilized by providers serving
ESRD patients in 250 transplant centers nationwide to
tailor LDKT education by race/ethnicity and based on the
needs of the individual patient. With additional testing in
other clinical settings and other patient populations, this
YPT program could be used in other healthcare settings
including in community nephrologists’ offices, in dialysis
centers, and even on the internet with patients and their
families learning at home. Only then can all ESRD patients
be assured the opportunity to learn about and pursue the
treatment option most beneficial to them – LDKT.
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